OBJECTIVES: Early initiation of antiretroviral therapy (ART) - that is, at higher CD4 cell counts (>350 cells/μl) - is a potent HIV prevention strategy. The WHO recommends ART initiation by all HIV-infected individuals in HIV serodiscordant relationships to prevent HIV transmission, yet the acceptability of early ART among couples has not been well studied. DESIGN: Qualitative study exploring HIV serodiscordant couples' attitudes toward early initiation of ART. METHODS: We conducted eight focus group discussions and 20 in-depth interviews with members of heterosexual HIV serodiscordant couples in Kenya. Investigators iteratively applied inductive and deductive codes, developed matrices to identify patterns in codes, and reached consensus on key attitudes (motivations and barriers) related to early ART and one central, emerging theme. RESULTS: Most participants expressed interest in early initiation of ART, with maintaining health and preventing HIV transmission as key benefits. However, many identified personal concerns and potential barriers to wider community acceptance, including side-effects, adherence to life-long treatment, and stigma. The meaning of ART emerged as a fundamental consideration, with initiating therapy perceived as emblematic of the final stage of AIDS, when one was 'nearing the grave.' One particular challenge was what early ART might signify for someone who looks and feels healthy. CONCLUSION: HIV serodiscordant couples recognized the potential benefits of early ART, but ART was frequently viewed as signifying AIDS and approaching mortality. Potential implementation of early ART presents challenges and an opportunity to re-orientate individuals toward a new image of ART as health-preserving for patients and partners.
OBJECTIVES: Early initiation of antiretroviral therapy (ART) - that is, at higher CD4 cell counts (>350 cells/μl) - is a potent HIV prevention strategy. The WHO recommends ART initiation by all HIV-infected individuals in HIV serodiscordant relationships to prevent HIV transmission, yet the acceptability of early ART among couples has not been well studied. DESIGN: Qualitative study exploring HIV serodiscordant couples' attitudes toward early initiation of ART. METHODS: We conducted eight focus group discussions and 20 in-depth interviews with members of heterosexual HIV serodiscordant couples in Kenya. Investigators iteratively applied inductive and deductive codes, developed matrices to identify patterns in codes, and reached consensus on key attitudes (motivations and barriers) related to early ART and one central, emerging theme. RESULTS: Most participants expressed interest in early initiation of ART, with maintaining health and preventing HIV transmission as key benefits. However, many identified personal concerns and potential barriers to wider community acceptance, including side-effects, adherence to life-long treatment, and stigma. The meaning of ART emerged as a fundamental consideration, with initiating therapy perceived as emblematic of the final stage of AIDS, when one was 'nearing the grave.' One particular challenge was what early ART might signify for someone who looks and feels healthy. CONCLUSION: HIV serodiscordant couples recognized the potential benefits of early ART, but ART was frequently viewed as signifying AIDS and approaching mortality. Potential implementation of early ART presents challenges and an opportunity to re-orientate individuals toward a new image of ART as health-preserving for patients and partners.
Authors: Alexander C Tsai; David R Bangsberg; Mwebesa Bwana; Jessica E Haberer; Edward A Frongillo; Conrad Muzoora; Elias Kumbakumba; Peter W Hunt; Jeffrey N Martin; Sheri D Weiser Journal: AIDS Behav Date: 2013-10
Authors: Wayne T Steward; Gregory M Herek; Jayashree Ramakrishna; Shalini Bharat; Sara Chandy; Judith Wrubel; Maria L Ekstrand Journal: Soc Sci Med Date: 2008-07-01 Impact factor: 4.634
Authors: Vivek Jain; Dathan M Byonanebye; Gideon Amanyire; Dalsone Kwarisiima; Doug Black; Jane Kabami; Gabriel Chamie; Tamara D Clark; James F Rooney; Edwin D Charlebois; Moses R Kamya; Diane V Havlir Journal: AIDS Date: 2014-09-24 Impact factor: 4.177
Authors: Margaret S Winchester; Janet W McGrath; David Kaawa-Mafigiri; Florence Namutiibwa; George Ssendegye; Amina Nalwoga; Emily Kyarikunda; Judith Birungi; Sheila Kisakye; Nicholas Ayebazibwe; Eddy J Walakira; Charles Rwabukwali Journal: Med Anthropol Q Date: 2016-08-21
Authors: Gabriel J Culbert; Alexander R Bazazi; Agung Waluyo; Astia Murni; Azalia P Muchransyah; Mariska Iriyanti; Maxim Polonsky; Judith Levy; Frederick L Altice Journal: AIDS Behav Date: 2016-05
Authors: Sheree R Schwartz; Nora West; Rebecca Phofa; Nompumelelo Yende; Ian Sanne; Jean Bassett; Annelies Van Rie Journal: Int J STD AIDS Date: 2015-09-18 Impact factor: 1.359